Tau aggregation inhibitors: the future of Alzheimer's pharmacotherapy?

  • Expert Opin Pharmacother. 2016;17(4):457-61. doi: 10.1517/14656566.2016.1146686.
Francesco Panza  1  2  3 ,  Davide Seripa  3 ,  Vincenzo Solfrizzi  4 ,  Bruno P Imbimbo  5 ,  Andrea Santamato  6 ,  Madia Lozupone  1 ,  Rosa Capozzo  1  2 ,  Camilla Prete  7 ,  Alberto Pilotto  7 ,  Antonio Greco  3 ,  Giancarlo Logroscino  1  2
Affiliations
  • 1. a Neurodegenerative Disease Unit, Department of Basic Medicine, Neuroscience, and Sense Organs , University of Bari Aldo Moro , Bari , Italy.
  • 2. b Department of Clinical Research in Neurology , University of Bari Aldo Moro, 'Pia Fondazione Cardinale G. Panico' , Lecce , Italy.
  • 3. c Geriatric Unit & Laboratory of Gerontology and Geriatrics, Department of Medical Sciences , IRCCS 'Casa Sollievo della Sofferenza' , Foggia , Italy.
  • 4. d Geriatric Medicine-Memory Unit and Rare Disease Centre , University of Bari Aldo Moro , Bari , Italy.
  • 5. e Research & Development Department , Chiesi Farmaceutici , Parma , Italy.
  • 6. f Physical Medicine and Rehabilitation Section, 'OORR' Hospital , University of Foggia , Foggia , Italy.
  • 7. g Department of OrthoGeriatrics, Rehabilitation and Stabilization, Frailty Area , E.O. Galliera NR-HS Hospital , Genova , Italy.
PMID: 26809554 DOI: 10.1517/14656566.2016.1146686
Products